Vibrio vulnificus biotype 2 serovar e gne but not galE is essential for lipopolysaccharide biosynthesis and virulence

Infection and Immunity

Volumn 76, Issue 4, 2008, Pages 1628-1638

  Valiente, Esmeralda ^a   Jiménez, Natalia ^b   Merino, Susana ^b   Tomas, Juan M ^b   Amaro, Carmen ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MEMBRANE ANTIGEN; MICROBICIDE; O ANTIGEN; TRANSFERRIN; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; EPIMERASE; GALACTOSE EPIMERASE; UDP-N-ACETYLGLUCOSAMINE 4-EPIMERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE 4 EPIMERASE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CARBOHYDRATE SYNTHESIS; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; DNA SEQUENCE; EEL; ENZYME ACTIVITY; GALE GENE; GENE FUNCTION; GENE ISOLATION; GENE MUTATION; GNE GENE; GROWTH CURVE; HUMAN; HYDROPHOBICITY; INNATE IMMUNITY; MOLECULAR CLONING; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTER MEMBRANE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; VIBRIO VULNIFICUS; VIRULENCE; ANIMAL; BIOFILM; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PHAGOCYTE; PHYSIOLOGY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL PROTEINS; BASE SEQUENCE; BIOFILMS; CARBOHYDRATE EPIMERASES; CHEMOTAXIS; CLONING, MOLECULAR; EELS; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PHAGOCYTES; PHAGOCYTOSIS; TRANSFERRIN; UDPGLUCOSE 4-EPIMERASE; VIBRIO VULNIFICUS; VIRULENCE;

EID: 42149135001     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01393-07     Document Type: Article

References (61)

1. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Amaro, C., B. Fouz, E. G. Biosca, E. Marco-Noales, and R. Collado. 1997. The lipopolysaccharide O side chain of Vibrio vulnificus serogroup E is a virulent determinant for eels. Infect. Immun. 65:2475-2479.
3. Amaro, C., and E. G. Biosca. 1996. Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans. Appl. Environ. Microbiol. 62:1454-1457.
4. Amaro, C., E. G. Biosca, B. Fouz, A. E. Toranzo, and E. Garay. 1992. Electrophoretic analysis of heterogeneous lipopolysaccharides from various strains of Vibrio vulnificus biotypes 1 and 2 using silver staining and inmunoblotting. Curr. Microbiol. 25:99-104.
5. Amaro, C., E. G. Biosca, B. Fouz, A. E. Toranzo, and E. Garay. 1994. Role of iron, capsule, and toxins in the pathogenicity of Vibrio vulnificus biotype 2 for mice Infect. Immun. 62:759-763.
6. Amaro, C., E. G. Biosca, B. Fouz, C. Esteve, and E. Alcalde. 1995. Evidence that water transmits Vibrio vulnificus serovar E infections to eels. Appl. Environ. Microbiol. 61:1133-1137.
7. Bengoechea, J. A., E. Pinta, T. Salminen, C. Oertelt, O. Holst, J. Radziejewska-Lebrecht, Z. Piotrowska-Seget, R. Venho, and M. Skurnik. 2002. Functional characterization of Gne (UDP-N-acetylglucosamine-4-epimerase), Wzz (chain length determinant), and Wzy (O-antigen polymerase) of Yersinia enterocolitica serotype O:8. J. Bacteriol. 184:4277-4287.
8. Bernatchez, S., C. M. Szymanski, N. Ishiyama, J. Li, H. C. Jarrell, P. C. Lau, A. M. Berghuis, N. M. Young, and W. W. Wakarchuk. 2005. A single bifunctional UDP-GlcNAc/Glc-4 epimerase supports the synthesis of three cell surface glycoconjugates in Campylobacter jejuni. J. Biol. Chem. 280:4792-4802.
9. Biosca, E. G., E. Garay, A. E. Toranzo, and C. Amaro. 1993. Comparison of the outer membrane protein profiles of Vibrio vulnificus biotypes 1 and 2. FEMS Microbiol. Lett. 107:217-222.
10. Biosca, E. G., H. Llorens, E. Garay, and C. Amaro. 1993. Presence of a capsule in Vibrio vulnificus biotype 2 and its relationship to virulence for eels. Infect. Immun. 61:1611-1618.
11. Bisharat, N., V. Agmon, R. Finkelstein, R. Raz, G. Ben-Dror, L. Lerner, S. Soboh, R. Colodner, D. N. Cameron, et al. 1999. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet 354:1421-1424.
12. Canals, R., N. Jiménez, S. Vilches, M. Regué, S. Merino, and J. M. Tomás. 2007. Role of Gne and GalE in the Virulence of Aeromonas hydrophila serotype O34. J. Bacteriol. 189:540-550.
13. Carlton, B. C., and B. J. Brown. 1981. Gene mutation, p. 224-225. In P. Gerhardt, R. G. E. Murray, R. N. Costilow, E. W. Nester, W. A. Wood, N. R. Krieg, and G. B. Phillips (ed.), Manual of methods for general bacteriology. American Society for Microbiology, Washington, DC.
14. Castro, R., N. Couso, A. Obach, and J. Lamas. 1999. Effect of different β-glucans on the respiratory burst of turbot (Psetta maxima) and gilthead seabream (Sparus aurata) phagocytes. Fish Shellfish Immunol. 9:529-541.
15. Chen, C. Y., K. M. Wu, Y. C. Chang, H. C. Tsai, T. L. Liao, Y. M. Liu, A. B. Shen, J. C. Li, T. L. Su, C. P. Shao, C. T. Lee, L. I. Hor, and S. F. Tsai. 2003. Comparative genome analysis of Vibrio vulnificus, a marine pathogen. Genome Res. 13:2577-2587.
16. Chen, Y., P. Bystricky, J. Adeyeye, P. Panigrahi, A. Ali, J. A Johnson, C. A. Bush, J. G. Morris, Jr., and O. C. Stine. 2007. The capsule polysaccharide structure and biogenesis for non-O1 Vibrio cholerae NRT36S: genes are embedded in the LPS region. BMC Microbiol. 7:20.
17. Creuzenet, C., M. Belanger, W. Wakarchuk, and J. S. Lam. 2000. Expression, purification and biochemical characterization of WbpP, a new UDP-GlcNAc C4 epimerase from Pseudomonas aeruginosa serotype O6. J. Biol. Chem. 275:19060-19067.
18. Esteve-Gassent, M. D., B. Fouz, R. Barrera, and C. Amaro. 2004. Efficacy of oral immunisation after immersion vaccination against Vibrio vulnificus in farmed European eels. Aquaculture 231:9-22.
19. Fouz, B., and C. Amaro. 2003. Isolation of a new serovar of Vibrio vulnificus pathogenic for eels cultured in freshwater farms. Aquaculture 217:677-682.
20. Fouz, B., M. D. Esteve-Gassent, R. Barrera, J. L. Larsen, M. E. Nielsen, and C. Amaro. 2001. Field testing of a vaccine against eel diseases caused by Vibrio vulnificus. Dis. Aquat. Org. 45:183-189.
21. Fouz, B., F. Roig, and C. Amaro. 2007. Phenotypic and genotypic characterization of a new fish-virulent Vibrio vulnificus serovar that lacks potential to infect humans. Microbiology 153:1926-1934.
22. Gunawardena, S., G. P. Reddy, Y. Wang, V. S. Kolli, R. Orlando, J. G. Morris, and C. A. Bush. 1998. Structure of a muramic acid containing capsular polysaccharide from the pathogenic strain of Vibrio vulnificus ATCC 27562. Carbohydr. Res. 309:65-76.
23. Hanahan, D. 1983. Studies on transformation of Escherichia coli with Plasmids. J. Mol. Biol. 166:557-580.
24. Hayat, U., G. P. Reddy, C. A. Bush, J. A. Johnson, A. C. Wright, and J. G. Morris. 1993. Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J. Infect. Dis. 168:758-762.
25. Hitchcock, P. J., and T. M. Brown. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154:269-277.
26. Hoben. J., and P. Somasegaran. 1982. Comparison of pour, spread, and drop plate methods for enumeration of Rhizobium spp. in inoculants made from presterilized peat. Appl. Environ. Microbiol. 44:1246-1247.
27. Ishikawaa, J., and K. Hotta. 1999. Frameplot: a new implementation of the frame analysis for predicting protein-coding regions in bacterial DNA with a high G+C content. FEMS Microbiol. Lett. 174:251-253.
28. Kim, C. M., R. Y. Park, J. H. Park, H. Y. Sun, Y. H. Bai, P. Y. Ryu, S. Y. Kim, J. H. Rhee, and S. H. Shin. 2006. Vibrio vulnificus vulnibactin, but not metalloprotease VvpE, is essentially required for iron-uptake from human holotransferrin. Biol. Pharm. Bull. 29:911-918.
29. Kim, Y. R., S. E. Lee, C. M. Kim, S. Y. Kim, E. K. Shin, D. H. Shin, S. S. Chung, H. E. Chey, A. Progulske-Fox, J. D. Hillman, M. Handfield, and J. H. Rhee. 2003. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun. 71:5461-5471.
30. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
31. Larsen, M. H., J. L. Larsen, and J. E. Olsen. 2001. Chemotaxis of Vibrio anguillarum to fish mucus: role of the origin of the fish mucus, the fish species and the serogroup of the pathogen. FEMS Microbiol. Ecol. 38:77-80.
32. Lee, C. T., C. Amaro, E. Sanjuan, and L. I. Hor. 2005. Identification of DNA sequences specific for Vibrio vulnificus biotype 2 strains by suppression subtractive hybridization. Appl. Environ. Microbiol. 71:5593-5597.
33. Lindahl, M., A. Faris, T. Wadstrom, and S. Hjerten. 1981. A new test based on "salting out" to measure relative surface hydrophobicity of bacterial cells. Biochim. Biophys. Acta 677:471-476.
34. Liu, P. V. 1957. Survey of hemolysin production among species of pseudomonads. J. Bacteriol. 74:718-722.
35. Lowry, O., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
36. Magre, S., Y. Takeuchi, G. Langford, A. Richards, C. Patience, and R. Weiss. 2004. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-α(1-3) galactosyl epitope. J. Virol. 78:5812-5819.
37. Marco-Noales, E., M. Milan, B. Fouz, E. Sanjuán, and C. Amaro. 2001. Transmission to eels, portals of entry, and putative reservoirs of Vibrio vulnificus serovar E (biotype 2). Appl. Environ. Microbiol. 67:4717-4725.
38. Martin, S. J., and R. J. Siebeling. 1991. Identification of Vibrio vulnificus O serovars with antilipopolysaccharide monoclonal antibody. J. Clin. Microbiol. 29:1684-1688.
39. Nesper, J., S. Schild, C. M. Lauriano, A. Kraiss, K. E. Klose, and J. Reidl. 2002. Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization. Infect. Immun. 70:5990-5996.
40. Nielsen, M. E., and M. D. Esteve-Gassent. 2006. The eel immune system: present knowledge and the need for research. J. Fish Dis. 29:65-78.
41. Oliver, J. D. 2006. Vibrio vulnificus, p. 349-366. In F. L. Thompson, B. Austin, and J. Swings (ed.), The biology of vibrios. ASM Press, Washington, DC.
42. Oliver, J. D., and R. R. Colwell. 1973. Extractable lipids of gram-negative marine bacteria: phospholipid composition. J. Bacteriol. 114:897-908.
43. Ørskov, F., and I. Ørskov. 1978. Serotyping of Enterobacteriaceae with special emphasis on K antigen determination. Methods Microbiol. vol. 11:37-38.
44. O'Toole, G. A., and R. Kolter. 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461.
45. Page, R. D. N. 1996. TREEVIEW: an application to display phylogenetic trees on personal computers. Comput. Applic. Biosci. 12:357-358.
46. Park, N. Y., J. H. Lee, B. C. Lee, T. S. Kim, and S. H. Choi. 2006. Identification and characterization of the wbpO gene essential for lipopolysaccharide synthesis in Vibrio vulnificus. J. Microbiol. Biotechnol. 16:808-816.
47. Park, N. Y., J. H. Lee, M. W. Kim, H. G. Jeong, B. C. Lee, T. S. Kim, and S. H. Choi. 2006. Identification of the Vibrio vulnificus wbpP gene and evaluation of its role in virulence. Infect. Immun. 74:721-728.
48. Reed, M. J., and M. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:487-493.
49. Rubirés, X., F. Saigí, N. Piqué, N. Climent, S. Merino, S. Albertí, J. M. Tomás, and M. Regué. 1997. A gene (wbbL) from Serratia marcescens N28b (024) complements the rfb-50 mutation of Escherichia coli K-12 derivatives. J. Bacteriol. 179:7581-7586.
50. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
51. Sanjuan, E., and C. Amaro. 2007. Multiplex PCR assay for detection of Vibrio vulnificus biotype 2 and simultaneous discrimination of serovar E. Appl. Environ. Microbiol. 73:2029-2032.
52. Solem, S. T., J. B. Jørgensen, and B. Robertsen. 1995. Stimulation of respiratory burst and phagocytic activity in Atlantic salmon (Salmo salar L.) macrophages by lipopolysaccharide. Fish Shellfish Immunol. 5:475-491.
53. Tison, D. L., M. Nishibuchi, J. D. Greenwood, and R. J. Seidler. 1982. Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels. Appl. Environ. Microbiol. 44:640-646.
54. Toguchi, A., M. Siano, M. Burkart, and R. M. Harshey. 2000. Genetics of swarming motility in Salmonella enterica serovar Typhimurium: critical role for lipopolysaccharide. J. Bacteriol. 182:6308-6321.
55. Towbin, H., T. Staehelin, and T. Gordon. 1979. Electrophoretic transfer of proteins from Polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
56. Valiente, E., and C. Amaro. 2006. A method to diagnose the carrier state of Vibrio vulnificus serovar E in eels. Aquaculture 258:173-179.
57. Wang, L., S. Huskic, A. Cisterne, D. Rothemund, and P. R. Reeves. 2002. The O-antigen gene cluster of Escherichia coli O55:H7 and identification of a new UDP-GlcNAc C4 epimerase gene. J. Bacteriol. 184:2620-2625.
58. Wright, A. C., J. G. Morris, D. R. Maneval, K. Richardson, and J. B. Kaper. 1990. Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect. Immun. 58:1769-1773.
59. Wright, A. C., J. L. Powell, J. B. Kaper, and J. Glenn Morris. 2001. Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect. Immun. 69:6893-6901.
60. Yano, T. 1992. Assays of hemolytic complement activity, p. 131-141. In J. S. Stolen, T. C. Fletcher, D. P. Anderson, S. L. Kaatari, and A. F. Rowley (ed.), Techniques in fish immunology. SOS Publications, New York, NY.
61. Yu, H. B., P. S. Srinivasa Rao, H. C. Lee, S. Vilches, S. Merino, J. M. Tomás, and K. Y. Leung. 2004. A type III secretion system is required for Aeromonas hydrophila AH-1 pathogenesis. Infect. Immun. 72:1248-1256.